世界の医薬品用超高バリアフィルム市場2020:製造企業別、地域別、種類別、用途別、市場予測2025

GlobalInfoResearchが発行した調査報告書(GIR20OC08075)
◆英語タイトル:Global Pharmaceutical Ultra-high Barrier Films Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20OC08075
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年10月(※2024年版があります。お問い合わせください。)
◆ページ数:103
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:化学・材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本書では、医薬品用超高バリアフィルムの世界市場を調査対象にし、医薬品用超高バリアフィルムの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(PET、CPP、BOPP、PVA、PLA、その他)、用途別分析(病院、診療所、その他)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:ACG Pharmapack、Toray Plastics、The Mondi Group、Amcor Limited、Glenroy, Inc、Winpak、Schur Flexibles Hoilding GesmbH、Constantia Flexibles、Berry Global Group、Cleplast Metallized Products、ProAmpac LLC.、FLAIR Flexible Packaging Corporation、Bischof and Klein GmbH and Co. KG、Dunmore Corporation
・メーカー別販売量、売上、市場シェア
・医薬品用超高バリアフィルムの地域別市場分析
・医薬品用超高バリアフィルムの北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・医薬品用超高バリアフィルムのヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・医薬品用超高バリアフィルムのアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・医薬品用超高バリアフィルムの南米市場規模2015-2020:ブラジル、アルゼンチンなど
・医薬品用超高バリアフィルムの中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・医薬品用超高バリアフィルムの種類別市場規模2015-2020:PET、CPP、BOPP、PVA、PLA、その他
・医薬品用超高バリアフィルムの用途別市場規模2015-2020:病院、診療所、その他
・医薬品用超高バリアフィルムの世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論
【レポートの概要】

Market Overview
The Pharmaceutical Ultra-high Barrier Films market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Pharmaceutical Ultra-high Barrier Films market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Pharmaceutical Ultra-high Barrier Films market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Pharmaceutical Ultra-high Barrier Films market has been segmented into
PET
CPP
BOPP
PVA
PLA
Others

By Application, Pharmaceutical Ultra-high Barrier Films has been segmented into:
Hospital
Clinic
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pharmaceutical Ultra-high Barrier Films market presented in the report. This section sheds light on the sales growth of different regional and country-level Pharmaceutical Ultra-high Barrier Films markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pharmaceutical Ultra-high Barrier Films market.

The report offers in-depth assessment of the growth and other aspects of the Pharmaceutical Ultra-high Barrier Films market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Pharmaceutical Ultra-high Barrier Films Market Share Analysis
Pharmaceutical Ultra-high Barrier Films competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pharmaceutical Ultra-high Barrier Films sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pharmaceutical Ultra-high Barrier Films sales, revenue and market share for each player covered in this report.

The major players covered in Pharmaceutical Ultra-high Barrier Films are:
ACG Pharmapack
Toray Plastics
The Mondi Group
Amcor Limited
Glenroy, Inc
Winpak
Schur Flexibles Hoilding GesmbH
Constantia Flexibles
Berry Global Group
Cleplast Metallized Products
ProAmpac LLC.
FLAIR Flexible Packaging Corporation
Bischof and Klein GmbH and Co. KG
Dunmore Corporation

Among other players domestic and global, Pharmaceutical Ultra-high Barrier Films market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Ultra-high Barrier Films product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pharmaceutical Ultra-high Barrier Films, with price, sales, revenue and global market share of Pharmaceutical Ultra-high Barrier Films in 2018 and 2019.
Chapter 3, the Pharmaceutical Ultra-high Barrier Films competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Ultra-high Barrier Films breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Pharmaceutical Ultra-high Barrier Films market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Pharmaceutical Ultra-high Barrier Films sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Pharmaceutical Ultra-high Barrier Films Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pharmaceutical Ultra-high Barrier Films Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 PET
1.2.3 CPP
1.2.4 BOPP
1.2.5 PVA
1.2.6 PLA
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Pharmaceutical Ultra-high Barrier Films Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Pharmaceutical Ultra-high Barrier Films Market
1.4.1 Global Pharmaceutical Ultra-high Barrier Films Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 ACG Pharmapack
2.1.1 ACG Pharmapack Details
2.1.2 ACG Pharmapack Major Business
2.1.3 ACG Pharmapack SWOT Analysis
2.1.4 ACG Pharmapack Product and Services
2.1.5 ACG Pharmapack Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Toray Plastics
2.2.1 Toray Plastics Details
2.2.2 Toray Plastics Major Business
2.2.3 Toray Plastics SWOT Analysis
2.2.4 Toray Plastics Product and Services
2.2.5 Toray Plastics Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 The Mondi Group
2.3.1 The Mondi Group Details
2.3.2 The Mondi Group Major Business
2.3.3 The Mondi Group SWOT Analysis
2.3.4 The Mondi Group Product and Services
2.3.5 The Mondi Group Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amcor Limited
2.4.1 Amcor Limited Details
2.4.2 Amcor Limited Major Business
2.4.3 Amcor Limited SWOT Analysis
2.4.4 Amcor Limited Product and Services
2.4.5 Amcor Limited Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Glenroy, Inc
2.5.1 Glenroy, Inc Details
2.5.2 Glenroy, Inc Major Business
2.5.3 Glenroy, Inc SWOT Analysis
2.5.4 Glenroy, Inc Product and Services
2.5.5 Glenroy, Inc Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Winpak
2.6.1 Winpak Details
2.6.2 Winpak Major Business
2.6.3 Winpak Product and Services
2.6.4 Winpak Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Schur Flexibles Hoilding GesmbH
2.7.1 Schur Flexibles Hoilding GesmbH Details
2.7.2 Schur Flexibles Hoilding GesmbH Major Business
2.7.3 Schur Flexibles Hoilding GesmbH Product and Services
2.7.4 Schur Flexibles Hoilding GesmbH Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Constantia Flexibles
2.8.1 Constantia Flexibles Details
2.8.2 Constantia Flexibles Major Business
2.8.3 Constantia Flexibles Product and Services
2.8.4 Constantia Flexibles Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Berry Global Group
2.9.1 Berry Global Group Details
2.9.2 Berry Global Group Major Business
2.9.3 Berry Global Group Product and Services
2.9.4 Berry Global Group Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Cleplast Metallized Products
2.10.1 Cleplast Metallized Products Details
2.10.2 Cleplast Metallized Products Major Business
2.10.3 Cleplast Metallized Products Product and Services
2.10.4 Cleplast Metallized Products Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 ProAmpac LLC.
2.11.1 ProAmpac LLC. Details
2.11.2 ProAmpac LLC. Major Business
2.11.3 ProAmpac LLC. Product and Services
2.11.4 ProAmpac LLC. Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 FLAIR Flexible Packaging Corporation
2.12.1 FLAIR Flexible Packaging Corporation Details
2.12.2 FLAIR Flexible Packaging Corporation Major Business
2.12.3 FLAIR Flexible Packaging Corporation Product and Services
2.12.4 FLAIR Flexible Packaging Corporation Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Bischof and Klein GmbH and Co. KG
2.13.1 Bischof and Klein GmbH and Co. KG Details
2.13.2 Bischof and Klein GmbH and Co. KG Major Business
2.13.3 Bischof and Klein GmbH and Co. KG Product and Services
2.13.4 Bischof and Klein GmbH and Co. KG Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Dunmore Corporation
2.14.1 Dunmore Corporation Details
2.14.2 Dunmore Corporation Major Business
2.14.3 Dunmore Corporation Product and Services
2.14.4 Dunmore Corporation Pharmaceutical Ultra-high Barrier Films Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Pharmaceutical Ultra-high Barrier Films Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Pharmaceutical Ultra-high Barrier Films Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pharmaceutical Ultra-high Barrier Films Manufacturer Market Share in 2019
3.3.2 Top 6 Pharmaceutical Ultra-high Barrier Films Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Pharmaceutical Ultra-high Barrier Films Sales, Revenue and Market Share by Regions
4.1.1 Global Pharmaceutical Ultra-high Barrier Films Sales and Market Share by Regions (2015-2020)
4.1.2 Global Pharmaceutical Ultra-high Barrier Films Revenue and Market Share by Regions (2015-2020)
4.2 North America Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
4.3 Europe Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
4.5 South America Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Pharmaceutical Ultra-high Barrier Films Sales, Revenue and Market Share by Country
5.1.1 North America Pharmaceutical Ultra-high Barrier Films Sales and Market Share by Country (2015-2020)
5.1.2 North America Pharmaceutical Ultra-high Barrier Films Revenue and Market Share by Country (2015-2020)
5.2 United States Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
5.3 Canada Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
5.4 Mexico Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Pharmaceutical Ultra-high Barrier Films Sales, Revenue and Market Share by Country
6.1.1 Europe Pharmaceutical Ultra-high Barrier Films Sales and Market Share by Country (2015-2020)
6.1.2 Europe Pharmaceutical Ultra-high Barrier Films Revenue and Market Share by Country (2015-2020)
6.2 Germany Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
6.3 UK Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
6.4 France Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
6.5 Russia Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
6.6 Italy Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Pharmaceutical Ultra-high Barrier Films Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Pharmaceutical Ultra-high Barrier Films Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Pharmaceutical Ultra-high Barrier Films Revenue and Market Share by Regions (2015-2020)
7.2 China Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
7.3 Japan Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
7.4 Korea Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
7.5 India Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
7.7 Australia Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Pharmaceutical Ultra-high Barrier Films Sales, Revenue and Market Share by Country
8.1.1 South America Pharmaceutical Ultra-high Barrier Films Sales and Market Share by Country (2015-2020)
8.1.2 South America Pharmaceutical Ultra-high Barrier Films Revenue and Market Share by Country (2015-2020)
8.2 Brazil Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
8.3 Argentina Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Pharmaceutical Ultra-high Barrier Films Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Pharmaceutical Ultra-high Barrier Films Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Pharmaceutical Ultra-high Barrier Films Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
9.3 Turkey Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
9.4 Egypt Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
9.5 South Africa Pharmaceutical Ultra-high Barrier Films Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Pharmaceutical Ultra-high Barrier Films Sales and Market Share by Type (2015-2020)
10.2 Global Pharmaceutical Ultra-high Barrier Films Revenue and Market Share by Type (2015-2020)
10.3 Global Pharmaceutical Ultra-high Barrier Films Price by Type (2015-2020)
11 Global Pharmaceutical Ultra-high Barrier Films Market Segment by Application
11.1 Global Pharmaceutical Ultra-high Barrier Films Sales Market Share by Application (2015-2020)
11.2 Global Pharmaceutical Ultra-high Barrier Films Revenue Market Share by Application (2015-2020)
11.3 Global Pharmaceutical Ultra-high Barrier Films Price by Application (2015-2020)
12 Market Forecast
12.1 Global Pharmaceutical Ultra-high Barrier Films Sales, Revenue and Growth Rate (2021-2025)
12.2 Pharmaceutical Ultra-high Barrier Films Market Forecast by Regions (2021-2025)
12.2.1 North America Pharmaceutical Ultra-high Barrier Films Market Forecast (2021-2025)
12.2.2 Europe Pharmaceutical Ultra-high Barrier Films Market Forecast (2021-2025)
12.2.3 Asia-Pacific Pharmaceutical Ultra-high Barrier Films Market Forecast (2021-2025)
12.2.4 South America Pharmaceutical Ultra-high Barrier Films Market Forecast (2021-2025)
12.2.5 Middle East & Africa Pharmaceutical Ultra-high Barrier Films Market Forecast (2021-2025)
12.3 Pharmaceutical Ultra-high Barrier Films Market Forecast by Type (2021-2025)
12.3.1 Global Pharmaceutical Ultra-high Barrier Films Sales Forecast by Type (2021-2025)
12.3.2 Global Pharmaceutical Ultra-high Barrier Films Market Share Forecast by Type (2021-2025)
12.4 Pharmaceutical Ultra-high Barrier Films Market Forecast by Application (2021-2025)
12.4.1 Global Pharmaceutical Ultra-high Barrier Films Sales Forecast by Application (2021-2025)
12.4.2 Global Pharmaceutical Ultra-high Barrier Films Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の医薬品用超高バリアフィルム市場2020:製造企業別、地域別、種類別、用途別、市場予測2025(Global Pharmaceutical Ultra-high Barrier Films Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。